Estelle Louiset

Estelle Louiset

Auto-generated profile, based on publicly available information

Estelle Louiset

Univ Rouen Normandie, Inserm, NorDic, UMR 1239, Adrenal and Gonadal Pathophysiology team

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2013 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
ELEstelle Louiset
Estelle Louiset
CDCéline Duparc
Céline Duparc
JYJacques Young
Jacques Young
SRSylvie Renouf
Sylvie Renouf
MNMilène Tetsi Nomigni
Milène Tetsi Nomigni
HLHerve Lefebvre
Herve Lefebvre
Bilateral macronodular adrenal hyperplasia is a rare cause of primary adrenal Cushing's syndrome. In this form of hyperplasia, hypersecretion of cortisol suppresses the release of corticotropin by pituitary corticotrophs, which results in low plasma corticotropin levels. Thus, the disease has been termed corticotropin-independent macronodular adrenal hyperplasia. We examined the abnormal production of corticotropin in these hyperplastic adrenal glands.

21 September 2017 in JCI Insight
Verified
Journal Article
Open access
PDF file
ALAnne-Lise Lecoq
Anne-Lise Lecoq
CSConstantine A. Stratakis
Constantine A. Stratakis
SVSay Viengchareun.
Say Viengchareun.
RCRonan Chaligné
Ronan Chaligné
LTLucie Tosca
Lucie Tosca
PKPeter Kamenický
Peter Kamenický
GIP-dependent Cushing’s syndrome is caused by ectopic expression of glucose-dependent insulinotropic polypeptide receptor (GIPR) in cortisol-producing adrenal adenomas or in bilateral macronodular adrenal hyperplasias. Molecular mechanisms leading to ectopic GIPR expression in adrenal tissue are not known. Here we performed molecular analyses on adrenocortical adenomas and bilateral macronodular adrenal hyperplasias obtained from 14 patients with GIP-dependent adrenal Cushing’s syndrome and one patient with GIP-dependent aldosteronism. GIPR expression in all adenoma and hyperplasia samples occurred through transcriptional activation of a single allele of the GIPR gene. While no abnormality was detected in proximal GIPR promoter methylation, we identified somatic duplications in chromosome region 19q13.32 containing the GIPR locus in the adrenocortical lesions derived from 3 patients. In 2 adenoma samples, the duplicated 19q13.32 region was rearranged with other chromosome regions, whereas a single tissue sample with hyperplasia had a 19q duplication only. We demonstrated that juxtaposition with cis -acting regulatory sequences such as glucocorticoid response elements in the newly identified genomic environment drives abnormal expression of the translocated GIPR allele in adenoma cells. Altogether, our results provide insight into the molecular pathogenesis of GIP-dependent Cushing’s syndrome, occurring through monoallelic transcriptional activation of GIPR driven in some adrenal lesions by structural variations.

29 May 2020 in Nature Communications
Verified
Journal Article
Open access
JWJulien Wils
Julien Wils
CDCéline Duparc
Céline Duparc
ACAnne-Françoise Cailleux
Anne-Françoise Cailleux
ALAntoine-Guy Lopez
Antoine-Guy Lopez
CGCaroline Guiheneuf
Caroline Guiheneuf
HLHerve Lefebvre
Herve Lefebvre
Aldosterone, produced by the adrenals and under the control of plasma angiotensin and potassium levels, regulates hydromineral homeostasis and blood pressure. Here we report that the neuropeptide substance P (SP) released by intraadrenal nerve fibres, stimulates aldosterone secretion via binding to neurokinin type 1 receptors (NK1R) expressed by aldosterone-producing adrenocortical cells. The action of SP is mediated by the extracellular signal-regulated kinase pathway and involves upregulation of steroidogenic enzymes. We also conducted a prospective proof-of-concept, double blind, placebo-controlled clinical trial aimed to investigate the impact of the NK1R antagonist aprepitant on aldosterone secretion in healthy male volunteers (EudraCT: 2008-003367-40, ClinicalTrial.gov: NCT00977223). Participants received during two 7-day treatment periods aprepitant (125 mg on the 1st day and 80 mg during the following days) or placebo in a random order at a 2-week interval. The primary endpoint was plasma aldosterone levels during posture test. Secondary endpoints included basal aldosterone alterations, plasma aldosterone variation during metoclopramide and hypoglycaemia tests, and basal and stimulated alterations of renin, cortisol and ACTH during the three different stimulatory tests. The safety of the treatment was assessed on the basis of serum transaminase measurements on days 4 and 7. All pre-specified endpoints were achieved. Aprepitant decreases aldosterone production by around 30% but does not influence the aldosterone response to upright posture. These results indicate that the autonomic nervous system exerts a direct stimulatory tone on mineralocorticoid synthesis through SP, and thus plays a role in the maintenance of hydromineral homeostasis. This regulatory mechanism may be involved in aldosterone excess syndromes.

20 July 2016 in Frontiers in Endocrinology
Verified
Journal Article
Open access
HLHerve Lefebvre
Herve Lefebvre
MTMichaël Thomas
Michaël Thomas
CDCéline Duparc
Céline Duparc
JBJérôme Bertherat
Jérôme Bertherat
ELEstelle Louiset
Estelle Louiset
In the normal human adrenal gland, steroid secretion is regulated by a complex network of autocrine/paracrine interactions involving bioactive signals released by endothelial cells, nerve terminals, chromaffin cells, immunocompetent cells and adrenocortical cells themselves. ACTH can be locally produced by medullary chromaffin cells and is therefore a major mediator of the corticomedullary functional interplay. Plasma ACTH also triggers the release of angiogenic and vasoactive agents from adrenocortical cells and adrenal mast cells, and thus indirectly regulates steroid production through modulation of the adrenal blood flow. Adrenocortical neoplasms associated with steroid hypersecretion exhibit molecular and cellular defects which tend to reinforce the influence of paracrine regulatory loops on corticosteroidogenesis. Especially, ACTH has been found to be abnormally synthesized in bilateral macronodular adrenal hyperplasia responsible for hypercortisolism. In these tissues, ACTH is detected in a subpopulation of adrenocortical cells which express gonadal markers. This observation suggests that ectopic production of ACTH may result from impaired embryogenesis leading to abnormal maturation of the adrenogonadal primordium. Globally, the current literature indicates that ACTH is a major player in the autocrine/paracrine processes occurring in the adrenal gland in both physiological and pathological conditions.

1 April 2015 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
CDCéline Duparc
Céline Duparc
LMLucile Moreau
Lucile Moreau
JDJose Felipe Golib Dzib
Jose Felipe Golib Dzib
HBHadrien-Gaël Boyer
Hadrien-Gaël Boyer
MNMilène Tetsi Nomigni
Milène Tetsi Nomigni
HLHervé Lefebvre
Hervé Lefebvre
Adrenal mast cells can stimulate aldosterone secretion through the local release of serotonin (5-HT) and activation of the 5-HT4 receptor (5-HT4). In aldosterone-producing adenomas (APAs), 5-HT4 receptor is overexpressed and the administration of 5-HT4 receptor agonists to patients with APA increases plasma aldosterone levels. These data and the well-documented role of mast cells in tumorigenesis suggest that mast cells may be involved in the pathophysiology of APA. The study aimed at investigating the occurrence of mast cells in a series of APA tissues and to examine the influence of mast cells on aldosterone secretion. The occurrence of mast cells in APAs was investigated by immunohistochemistry. Mast cell densities were compared with clinical data. The influence of mast cells on aldosterone production was studied by using cultures of human mast cell and adrenocortical cell lines. In APA tissues, the density of mast cells was found to be increased in comparison with normal adrenals. Mast cells were primarily observed in adrenal cortex adjacent to adenomas or in the adenomas themselves, distinguishing two groups of APAs. A subset of adenomas was found to contain a high density of intratumoral mast cells, which was correlated with aldosterone synthase expression and in vivo aldosterone secretory parameters. Administration of conditioned medium from cultures of human mast cell lines to human adrenocortical cells induced a significant increase in aldosterone synthase (CYP11B2) mRNA expression and aldosterone production. APA tissues commonly contain numerous mast cells that may influence aldosterone secretion through the local release of regulatory factors.

1 January 2019
Verified
Book Chapter
Closed access
HLHerve Lefebvre
Herve Lefebvre
CDCéline Duparc
Céline Duparc
ANAlexandre Naccache
Alexandre Naccache
ALAntoine-Guy Lopez
Antoine-Guy Lopez
MCMireille Castanet
Mireille Castanet
ELEstelle Louiset
Estelle Louiset